| FOXO | forkhead box family |
| GSK3β | glycogen synthase kinase-3β |
| HIF-1α | hypoxia-induced factor-1α |
| ICP | intranasally administered proinsulin C-peptide |
| IGF-1 | insulin-like growth factor-1 |
| INI | intranasally administered insulin |
| INSR | insulin receptor |
| IR | insulin resistance |
| IRS | insulin receptor substrates |
| JNK1 | c-Jun N-terminal kinase-1 |
| LPO | lipid peroxidation |
| MAPK | mitogen-activated protein kinase |
| mitoBKCa | mitochondrial ATP-sensitive large-conductance Ca2+-activated potassium channels |
| MS | metabolic syndrome |
| mTORC complex | the mammalian target of rapamycin complex |
| p21kip | a cyclin-dependent kinase inhibitor 1 |
| PDK1/2 | 3-phosphatidylinositol-dependent protein kinases of types 1 and 2 |
| PGC1α | peroxisome proliferator-activated receptor γ coactivator 1-α |
| PHLPP | PH domain and Leucine-rich repeat Protein Phosphatases |
| PI-3,4,5-P3 | phosphatidylinositol-3,4,5-triphosphate |
| PI3K | phosphatidylinositol-3-kinase |
| pNCD | postoperative neurocognitive disorder |
| POD | postoperative delirium |
| PP-1 | protein phosphatase-1 |
| PTP1B | protein phosphotyrosine phosphatase 1B |
| SHIP2 | type 2 SH2-containing inositol-5’-phosphatase |
| SREBP1 | sterol regulatory element-binding transcription factor 1 |
| T1DM | type 1 diabetes mellitus |
| T2DM | type 2 diabetes mellitus |
| TBI | traumatic brain injury |
| TC-PTP | T-cell protein phosphotyrosine phosphatase |
| TSC1/2 | tuberous sclerosis proteins 1 (hamartin) and 2 (tuberin) |